GI
KRYS icon

GAMMA Investing’s Krystal Biotech KRYS Stock Holding History

GAMMA Investing’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Buy
998
+140
+16% +$41.8K 0.01% 822
2026
Q1 		$222K Buy
858
+69
+9% +$18.4K 0.01% 1039
2025
Q4 		$195K Buy
789
+292
+59% +$61.5K 0.01% 1068
2025
Q3 		$87.7K Buy
497
+212
+74% +$31.7K ﹤0.01% 1593
2025
Q2 		$39.2K Sell
285
-388
-58% -$57K ﹤0.01% 2074
2025
Q1 		$121K Buy
673
+432
+179% +$72.7K 0.01% 1099
2024
Q4 		$37.8K Sell
241
-189
-44% -$33.5K ﹤0.01% 1874
2024
Q3 		$78.3K Buy
430
+279
+185% +$53.8K 0.01% 1169
2024
Q2 		$27.7K Buy
151
+93
+160% +$15.6K ﹤0.01% 1642
2024
Q1 		$10.3K Buy
58
+16
+38% +$2.22K ﹤0.01% 2054
2023
Q4 		$4.67K Buy
+42
New +$4.66K ﹤0.01% 2268

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

GAMMA Investing's KRYS Position: Q2 2026 in Review

GAMMA Investing increased its Krystal Biotech (KRYS) stake by 16% in Q2 2026, buying an estimated $41.8K and bringing the position to 998 shares worth $371K. The position accounts for 0.01% of the portfolio, ranked #822.

GAMMA Investing first reported a position in KRYS in Q4 2023 and has held it in 11 quarters since. 65 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • GAMMA Investing held 998 shares of Krystal Biotech worth $371K as of Q2 2026.
  • GAMMA Investing bought 140 Krystal Biotech shares in Q2 2026, an estimated $41.8K.
  • Krystal Biotech made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #822 holding.
  • GAMMA Investing first reported a position in Krystal Biotech in Q4 2023 and has held it in 11 quarters since.
  • 65 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.